Last week, something unexpected happened during one of my shared medical visits with patients. I wasn’t expecting shame to show up. We were deep in conversation about how a diagnosis can unravel a person’s identity and how grief often follows when our sense of self begins to slip away.
Read more
Vidofludimus calcium, an experimental oral therapy from Immunic Therapeutics, reduced the risk of confirmed disability worsening and slowed brain shrinkage in people with progressive forms of multiple sclerosis (MS). That’s according to top-line data from CALLIPER (NCT05054140), a Phase 2 clinical trial testing a daily dose of…
The Multiple Sclerosis Association of America (MSAA) will host its 11th annual Improving Lives Benefit on May 14 to bring together members of the multiple sclerosis (MS) community, celebrate achievements, and raise support for the organization’s free programs and services. The fundraising event will take place at…
Even though I was too young to see the first three “Star Wars” films in theaters, I’ve watched them many, many times over the years. I don’t know if it’s the same everywhere, but here in the U.S., their enormous impact on pop culture is undeniable. Nearly everyone you meet…
Octave Bioscience’s Multiple Sclerosis Disease Activity (MSDA) test, which uses data from blood biomarkers to assess multiple sclerosis (MS) disease activity, is now available across all 50 U.S. states to help guide clinicians’ decisions about care. Octave said the test received certification from the New York State Clinical…
Get regular updates to your inbox.
